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Abstract: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism. Accumulation of ROS without
an effective antioxidant response can lead to oxidative stress, resulting in macromolecular damage that is implicated in the etiology of
various diseases including cancer. ROS detoxification is regulated by various antioxidant proteins, specifically manganese superoxide
dismutase (MnSOD), which catalyzes the conversion of superoxide into H2O2, and the subsequent conversion of H2O2 into water is
catalyzed by glutathione peroxidase 1 (GPx-1). In vitro and in vivo evidence supports a conflicting role of MnSOD in tumor biology and
indicates that an interaction between MnSOD and GPx-1 can modulate the impact of MnSOD on carcinogenesis. Additional support
for this idea is provided by epidemiological data indicating that an association exists between polymorphisms in the MnSOD and GPx-1
genes and cancer risk, such that individuals who carry both at-risk polymorphisms are at a higher risk of several types of cancer. Future
studies examining the impact of these 2 antioxidants on tumor biology need to consider the interplay between the 2 genes.
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1. Oxidative Stress
The generation of ATP via oxidative phosphorylation
provides the energy required by aerobic organisms
to sustain themselves. This process is localized to the
mitochondria, where electrons are passed among the
components of the electron transport chain where there
is an inevitability of leakage of the highly reactive oxygen
species (ROS) superoxide, with it having been estimated
that 1%–2% of the oxygen being used for mitochondrial
respiration is converted to superoxide. With its short halflife and extreme reactivity, there is a strong potential for the
superoxide radical to interact with biomolecules, resulting
in oxidative damage that could have a profound effect on
cellular function and survivability. As described below,
eukaryotic cells have evolved defense mechanisms to
protect themselves from the adverse effects of superoxide
accumulation and the strategic location of manganese
superoxide dismutase (MnSOD) in the mitochondria
is a principle one of these. As a consequence of the
dismutation of superoxide by MnSOD, the less reactive
hydrogen peroxide (H2O2) is generated, which can diffuse
through the mitochondrial membrane where it can have
its own host of biological consequences. The management
of the appropriate levels of ROS is the domain of a host
of antioxidant molecules such as glutathione and enzymes
* Correspondence: adiamond@uic.edu
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that can neutralize ROS. Oxidative stress occurs when the
levels of ROS exceed the cell’s abilities to maintain them
at their appropriate levels. While less considered, the
elimination of ROS past the ideal levels to support cellular
function may also occur, and this has been referred to as
reductive stress.
2. ROS as important signaling molecules
Aerobic organisms have not only evolved to take advantage
of the enhanced energy production that can be achieved
by the consumption of oxygen via the electron transport
chain, but have also evolved to use ROS as potent signaling
molecules. Fluctuations in ROS can be due to changes in
environmental stimuli or intrinsic metabolic activity, and
examples abound throughout phylogeny indicating the
sensing of and response to one ROS, H2O2. As examples,
plants use an oxidative burst that generates H2O2 that serves
as a diffusible signal to induce apoptosis in pathogenexposed cells while stimulating antioxidant enzymes in
adjacent tissues (Levine et al., 1994), and a H2O2 gradient
generated at the tissue level in zebrafish mediates wound
healing and leukocyte recruitment (Niethammer et al.,
2009). One of the first examples of H2O2 being critical
for normal mammalian functions was the demonstration
that the production of H2O2 could stimulate platelet-
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derived growth factor, whose activity results in a variety of
cellular responses, including DNA synthesis, replication,
and chemotaxis (Sundaresan et al., 1995). A significant
component of ROS signaling is the consequence of the
oxidation of reactive cysteine residues in catalytic proteins
and one estimate has there being over 500 individual
proteins that might be regulated in this manner, with many
being tyrosine and multispecific phosphatases (Weerapana
et al., 2010; Finkel, 2011). Thus, there is a critical need to
have an understanding of the regulation and maintenance
of ROS, and H2O2 in particular given its relative stability
compared to other ROS species, in cellular processes and
homeostasis. This need extends to the roles played by
the antioxidant enzymes above that are more frequently
examined in the prevention of cellular damage and the
response to oxidative stress.
3. MnSOD
MnSOD is a nuclear-encoded and mitochondrially located
enzyme that removes superoxide by reducing it to the
less toxic H2O2, and it is essential for all aerobically living
organisms (Fridovich, 1975). While numerous reports
have been published indicating a protective effect of
increasing MnSOD in cultured cells, others have reported
enhanced toxicity, particularly in a cellular environment
in which other antioxidant defenses have been reduced.
For example, enhanced cytotoxicity and oxidative stress
from 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) are
reported when MnSOD is overexpressed in different cell
types (Darby-Weydert et al., 2003; Weydert et al., 2008).
BCNU has been shown to inactivate important antioxidant
enzymes such as glutathione reductase and thioredoxin
reductase (Schallreuter et al., 1990).
There is extensive literature that addresses the role
MnSOD plays in tumorigenesis, including cell culture
work, animal models, and the examination of changes in
MnSOD levels in tumors relative to the corresponding
normal tissues, although there are data indicating that
the consequences of MnSOD levels may either suppress
or promote carcinogenesis. The reader is referred to
2 excellent reviews on this subject, the first from over
30 years ago for a historical perspective (Oberley and
Buettner, 1979) and the second more recent (Dhar and
St Clair, 2012). A critical paper indicating that elevated
MnSOD levels could suppress carcinogenesis was
published in 1993 by Church et al. (Church et al., 1993).
Using human UACC-903 melanoma cells, they reported
that the ectopic expression of MnSOD in those cells
reduced their ability to form colonies in soft agar and
tumors when injected in immunosuppressed mice, both
hallmarks of the transformation process (Church et al.,
1993). Subsequently, there have been numerous reports
of the elevated expression of MnSOD attenuating the

characteristics of cancer cells in culture and limiting the
ability of xenografted tumor cells in mice, and these have
been recently reviewed (Holley et al., 2013). Alternatively,
overexpression of MnSOD in tumor cells has been shown
to be protective against tumor cell death by either serum
starvation or the induction of apoptosis (Palazzotti et al.,
1999; Mohr et al., 2008).
4. The interaction between MnSOD and other
antioxidants
An important mechanism by which MnSOD enzyme
activity could impact tumor biology is the production
of H2O2, which could stimulate the expression of genes
involved in carcinogenesis and metastasis. This concept is
supported by data indicating that the increased expression
of MnSOD in U87 glioma cells achieved due to transfection
of an MnSOD expression construct could increase cell
migration, invasive properties, activation of signaling
cascades associated with transformation, levels of the
MMP-1 and MMP-9 matrix metalloproteinases, and that
each of these could be suppressed by the addition of the
antioxidant compound N-acetyl-1-cysteine that reduces
hydrogen peroxide (Li et al., 2011). The effects of these
treatments were due to the specific reduction in H2O2, which
was established using a mitochondrially targeted catalase
that also reversed the effects of MnSOD overexpression
(Li et al., 2011). Using HT-1080 fibrosarcoma cells, it
was shown that overexpression of MnSOD increased the
binding of transformation-associated transcription factors
as well as the expression of matrix metalloproteinase-1,
a metastasis-related protein, and these effects could also
be abrogated by the enhanced expression of catalase
(Nelson et al., 2003). One of the earliest reports of H2O2
detoxifying enzymes altering the tumorigenic effects of
MnSOD was published in 2000 when Li et al. investigated
the effects of overexpressing another H2O2 detoxifying
enzyme, glutathione peroxidase 1 (GPx-1), on MnSODinduced phenotypes associated with carcinogenesis (Li et
al., 2000). Here, the human glioma P U118-9 cell line was
transfected with an expression construct, which resulted in
the overexpression of MnSOD. Increased levels of MnSOD
led to decreased doubling time, plating efficiency, and,
when implanted into nude mice, reduced tumor growth.
All of these changes were suppressed by the increased
expression of GPx-1 achieved by the transfection of a GPx1 expression construct into the MnSOD-overexpressing
cells (Li et al., 2000).
5. Glutathione peroxidase 1 (GPx-1)
One protein involved in the regulation of H2O2 levels is the
selenium-dependent enzyme GPx-1. GPx-1 is a member
of a highly unusual family of proteins that contain the
essential trace element selenium in the form of the amino
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acid selenocysteine (Hatfield and Gladyshev, 2002). For
these proteins, selenium is inserted cotranslationally in
response to one or more in-frame UGA codons, destined
to be recognized as selenocysteine due to the presence
of a selenium insertion sequence element in the 3’
untranslated region of the selenoprotein mRNA (Berry
et al., 1991; Caban and Copeland, 2006). GPx-1 was the
first characterized selenoprotein and functions to detoxify
hydrogen and lipid peroxides using reducing equivalents
from glutathione, although broader roles in reactive
oxygen-mediated signaling pathways have been supported
by experimental data in addition to the more focusedupon role as an antioxidant [see Lubos et al. (2010) for a
comprehensive review].
GPx-1 is a selenium-dependent enzyme that is critical
in eliminating H2O2. Approximately 50% of GPx-1 is
located in the mitochondria, where superoxide is formed
as a consequence of electron transport and where MnSOD
resides (Arthur, 2000). A polymorphism in the GPx1 gene, resulting in a leucine (leu) at codon 198 rather
than a proline (pro), is associated with increased risk of
cancers of the lung, breast, bladder, and liver as well as
lymphoma [reviewed by Zhuo and Diamond (2009)].
In addition to cancer, allelic variants of GPx-1 have also
been associated with the risk of cardiomyopathy (Lei
et al., 2009), coronary heart disease (Winter et al., 2003;
Tang et al., 2008), hypertension (Kato et al., 2008), autism
(Ming et al., 2010), intracerebral hemorrhage (Pera et al.,
2008), asthma (Solodilova et al., 2007), and metabolic
syndrome (Solodilova et al., 2007). The at-risk GPx-1 leu
allele encodes a protein that is less responsive to selenium
as compared to the same protein with a proline at that
position (Hu and Diamond, 2003; Zhuo et al., 2009).
6. Epidemiological evidence for a role of MnSOD in
cancer
In addition to data obtained using cultured cells and
animal models, there is also considerable human data
indicating a role for MnSOD in carcinogenesis. It is
difficult to arrive at a clear indication as to whether
MnSOD levels are beneficial or harmful to patients with
cancers because, as recently summarized, the levels of
MnSOD in tumors can be higher or lower than that
observed in the corresponding normal tissue (Dhar and St
Clair, 2012). However, a variant MnSOD allele encoding an
alanine (A) rather than a valine (V) at codon 16 has been
described, and in several reports it has been associated
with an elevated cancer risk, including the risk of prostate
cancer, in human epidemiological studies (Li et al., 2005;
Sutton et al., 2006; Kang et al., 2007; Mikhak et al., 2008).
As a consequence of alanine being at this position in the
mitochondrial import signal peptide, there is increased
transport of MnSOD into the mitochondria as well as
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increased MnSOD mRNA stability (Sutton et al., 2005).
While it might be counterintuitive that elevated levels of
an antioxidant enzyme would increase risk, several studies
have shed light on the likely explanation. Li et al. reported
an impressive 10-fold swing in the risk of aggressive
prostate cancer among men who expressed the AA
genotype between the lowest quartile of total antioxidant
consumption and the highest, with those consuming the
lowest levels of dietary antioxidants being at the greatest
risk (Li et al., 2005). Similarly, it was reported that there
was a 3-fold increase risk of aggressive prostate cancer for
AA men with low carotenoid status (P = 0.02, confidence
interval: 1.37–7.02) (Mikhak et al., 2008). As originally
proposed by Li et al., it is therefore possible that increased
mitochondrial transport of MnSOD as a consequence of
a codon 16 alanine is beneficial when antioxidant activity
is high and the MnSOD dismutation product, H2O2, can
be reduced to water (Li et al., 2005). A low antioxidant
status, defined either by individual genetics and/or dietary
intake, could facilitate the cycling of H2O2 to more ROS
that are potentially mutagenic and therefore carcinogenic.
Alternatively, peroxidase activity of the MnSOD protein
may directly result in the oxidation of protein and DNA
(Ansenberger-Fricano et al., 2013). Thus, the same allelic
variant may be beneficial under some circumstances and
detrimental under others.
7. The interaction between MnSOD and GPx-1 in
human cancers
While the results described above indicate an effect of the
intake of dietary antioxidants on the ultimate carcinogenic
consequences of MnSOD genotype, there are also data
on the interaction between MnSOD and GPx-1 in cancer
etiology. An interaction between MnSOD and GPx-1 in
contributing to cancer risk was reported by Cox et al., who
initially reported that there was no association between
the at-risk leu allele of GPx-1 and breast cancer risk among
participants of the Nurse’s Health Study (Cox et al., 2004).
However, a follow-up study by the same authors indicated
that there was indeed a significant risk for breast cancer
among participants of the same cohort when the MnSOD
genotypes were also considered; carriers of both the AA
and leu/leu genotype were at increased risk of breast
cancer with an odds ratio of 1.87 (95% confidence level:
1.09–3.19) (Cox et al., 2006). These human data indicate
an interaction between MnSOD and GPx-1 in influencing
cancer risk. GPx-1 may be a particularly important H2O2detoxifying enzyme because of its cellular location in
the mitochondria and cytoplasm, as well as the nucleus
(Utsunomiya et al., 1991; Asayama et al., 1994; Li et al.,
2000). Further support for this interaction comes from
human data indicating that polymorphisms in the gene for
the selenium transport protein selenoprotein P (SEPP1),
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which result in less SEPP1 in the plasma and reduced
levels of GPx-1, are associated with a significant risk of
aggressive prostate cancer only in men also expressing the
ala16 MnSOD allele (Cooper et al., 2008).
A dramatic 10-fold differential was found in the risk of
aggressive prostate cancer among individuals homozygous
for the alanine-expressing MnSOD allele when those
with low intake of antioxidants were compared to those
with the greatest intake (Li et al., 2005). Additionally, it
was observed that those who express this allele are also
at greater risk of cancer if they express the at-risk alleles
of GPx-1 or SEPP1 (Cox et al., 2006; Cooper et al., 2008).
Taken together, it is apparent that the frequency of these
alleles in the human population is a significant factor.
The ala16 MnSOD allele is common, with approximately
25% of healthy participants of the Physician’s Health
Study having that genotype (Li et al., 2005). Genotype
frequencies for the MnSOD, GPx-1 (Cox et al., 2004), and
SEPP1 (Steinbrecher et al., 2010) genes are presented below

in the Table. A diagrammatic representation of the dietary
and genetic factors that may participate in determining the
risk of cancer due to the expression of the ala16 MnSOD
allele is presented below in the Figure.
8. Conclusion
A greater understanding of the role of MnSOD in cancer
etiology has been achieved using in vitro, in vivo, and
epidemiological approaches. Although some results are
conflicting, these studies provide insight into how GPx1 and MnSOD function to influence the physiology of
normal and cancer cells. Several mechanisms have been
proposed to explain the role of MnSOD in carcinogenesis
with existing evidence indicating that these effects by
which MnSOD impacts carcinogenesis can be influenced
by GPx-1 activity. An interaction between these 2 enzymes
is apparent where the mitochondrial resident protein
MnSOD detoxifies superoxide to H2O2, which can be
further reduced to water by GPx-1, which is also located

Table. Frequencies of anticipated genetic modifiers of MnSOD-associated disease risk.
Gene

Genotype frequencies

MnSOD

Val/Val

Val/Ala

Ala/Ala

24.9%

49.6%

25.5%

Pro/Pro

Pro/Leu

Leu/Leu

47.2%

40.4%

2.4%

Ala/Ala

Ala/Thr

Thr/Thr

55.1%

39.4%

5.5%

GPx-1

SEPP1

Figure. Model for the interaction among endogenous and environmental sources of oxidative stress,
individual genotype, and risk of cancer and other degenerative disease. Elevated expression and/
or activity of MnSOD results in enhanced dismutation of superoxide and an additional load of
H2O2, which, if detoxified, will be beneficial. In contrast, reduced levels of GPx-1, as a result of
polymorphisms in GPx-1 or SEPP1, or reduced selenium/antioxidant levels, will increase the levels
of H2O2 and contribute to cancer and degenerative disease risk as well.
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in the mitochondria. Epidemiological studies examining
the association between MnSOD and cancer support the
interaction of the 2 genes, and specifically the impact of
polymorphisms in MnSOD and GPx-1. Future studies
should include the examination of the levels and genotypes
of both proteins in order to grasp the importance of how

altered redox may affect the physiology of both normal
and cancer cells.
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